Kaplan et al., 2010 - Google Patents
The bradykinin-forming cascade and its role in hereditary angioedemaKaplan et al., 2010
- Document ID
- 12324344529700967518
- Author
- Kaplan A
- Joseph K
- Publication year
- Publication venue
- Annals of Allergy, Asthma & Immunology
External Links
Snippet
OBJECTIVE: To review the mechanisms by which bradykinin is generated in hereditary angioedema (HAE)(C1 inhibitor deficiency), including the role of human plasma proteins and endothelial cells. DATA SOURCES: Published articles in reviewed journals that address …
- 206010019860 Hereditary angioedema 0 title abstract description 101
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaplan et al. | The bradykinin-forming cascade and its role in hereditary angioedema | |
Kaplan et al. | The plasma bradykinin-forming pathways and its interrelationships with complement | |
AU666854B2 (en) | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting | |
Bernkop-Schnürch | The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins | |
Sala et al. | A functional assay of protein C in human plasma | |
Lin et al. | Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro | |
Sherry et al. | Proteolytic enzymes: a therapeutic evaluation | |
JP2003514790A (en) | Method for thrombolysis by local delivery of reversibly inactivated acidified plasmin | |
Ishii et al. | Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells | |
KR20140033010A (en) | Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor | |
JPH06184196A (en) | Peptides derived from vitronectin and medicinal compositionscontaining them | |
BR112014004297B1 (en) | USE OF AN ANTITHROMBIN III INHIBITOR IN THE TREATMENT OR PREVENTION OF BLEEDING | |
Råanby et al. | Biological control of tissue plasminogen activator-mediated fibrinolysis | |
Seitz et al. | Prothrombin activation by thrombolytic agents | |
Stenman | Tumour-associated trypsin inhibitor and tumour-associated trypsin | |
Pechet et al. | The effect of certain proteolytic enzymes on the thrombin-fibrinogen interaction | |
Desmazes et al. | Cathepsin L, but not cathepsin B, is a potential kininogenase | |
Coleman et al. | Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone | |
NZ515063A (en) | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor | |
Kaplan | Kinins, airway obstruction, and anaphylaxis | |
Lombardi et al. | Imbalance between Plasminogen Activator and its Inhibitors in Thiol-Lnduced Acantholysis | |
Frank | Hereditary angio-oedema | |
Patrassi et al. | The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril | |
AU2003213856B2 (en) | Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy | |
Jacobsen | The antiplasmin activity of human plasma and serum and its dependence on ions |